Date Added: Sep 2010
Pharmaceutical companies face complex issues that grow more challenging by the day. Healthcare reform and changes in technology, government policy and consumer expectations are revolutionizing relationships with key stakeholders and impacting operations in unforeseen ways. Globalization is presenting its own set of challenges that span multiple levels of most pharmaceutical organizations - from marketing to regulatory. Add to the mix the "Patent cliff," a sagging economy, shrinking R&D budgets and lackluster sales pipelines and you have a recipe that would challenge even the most seasoned leadership team.